• If you are wondering whether Colgate-Palmolive at around US$81.48 is a fair deal or a stretch, you are in the right place to unpack what that price might really be offering you.
• The stock has returned 4.9% over the last week and 4.8% over the last month, while the 1 year return sits at a 3.4% decline and the 3 and 5 year returns are 12.4% and 11.9% respectively.
• Recent coverage around Colgate-Palmolive has focused on its position as a global consumer staples brand and how investors treat it as a core holding in household and personal care. This context helps frame why the share price can move even on relatively small shifts in sentiment about defensiveness, income potential, or long term brand strength.
• Simply Wall St gives Colgate-Palmolive a valuation score of 2 out of 6. This reflects where the company screens as undervalued on some checks and less so on others. Next we will look at those methods in detail before finishing with a more complete way to think about valuation overall.

Colgate-Palmolive scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Colgate-Palmolive Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today’s value to estimate what the business might be worth right now.

For Colgate-Palmolive, the model uses a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about $3.38b. Analyst inputs and subsequent extrapolations point to free cash flow of $4.18b by 2030, with values in between built from a mix of analyst estimates for the next few years and Simply Wall St extrapolations after that.

Bringing those projected cash flows back to today using the DCF method gives an estimated intrinsic value of US$123.74 per share. Compared with the recent share price of about US$81.48, this model indicates the stock is 34.2% below that intrinsic estimate, which screens as undervalued on this approach.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Colgate-Palmolive is undervalued by 34.2%. Track this in your watchlist or portfolio, or discover 879 more undervalued stocks based on cash flows.

Approach 2: Colgate-Palmolive Price vs Earnings

For a profitable business like Colgate-Palmolive, the P/E ratio is a useful yardstick because it ties the share price directly to the earnings the company is currently generating. Investors usually expect a higher P/E when they anticipate stronger growth or see lower risk, and a lower P/E when they want more compensation for uncertainty around earnings.

Colgate-Palmolive is trading on a P/E of 22.59x, compared with the Household Products industry average of 16.65x and a peer group average of 19.83x. Simply Wall St also calculates a proprietary “Fair Ratio” of 18.93x, which is the P/E level that might be expected given Colgate-Palmolive’s earnings growth profile, industry, profit margins, market cap and risk factors.

This Fair Ratio is more tailored than a simple comparison with peers or the broad industry, because it adjusts for the company’s own fundamentals rather than assuming all businesses in the sector deserve the same multiple. Compared with the current 22.59x P/E, Colgate-Palmolive is priced above this Fair Ratio, which indicates that the shares screen as overvalued on this measure.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1443 companies where insiders are betting big on explosive growth.

Upgrade Your Decision Making: Choose your Colgate-Palmolive Narrative

Earlier we mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St’s Community page let you attach your own story about Colgate-Palmolive to the numbers by linking your view of its future revenue, earnings and margins to a forecast. That can then be turned into a fair value and compared with the current price to help you decide whether you see the shares as attractive or not. This view is updated automatically when fresh news or earnings arrive. Some investors might back a higher fair value closer to the US$106 target based on confidence in emerging market growth and efficiency gains, while others might anchor nearer the US$83 target if they focus more on cost pressures, competition and softer category trends.

Do you think there's more to the story for Colgate-Palmolive? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.